Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-05-002661
Filing Date
2005-08-04
Accepted
2005-08-04 17:09:56
Documents
1
Period of Report
2005-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 2938
  Complete submission text file 0001005477-05-002661.txt   4811
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORPORATION 41 SEYON STREET, BUILDING 1, WALTHAM MA 02453
Business Address 781-250-0111
Whitehouse Laura (Reporting) CIK: 0001289428 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 051000175